
\begin{table}[htb]\centering
\caption{Logit Coefficients \\ Dependent variable: Restrictive PPM}
\begin{tabular}{l*{8}c}

 & (1) & (2) & (3) & (4) & (5) & (6) & (7) & (8)  \\
 & All & All & All & All (clustered SE) & Recent & Recent & Recent & Recent (clustered SE)  \\


                    &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   &        b/se   \\

\hline

       &               &               &               &               &               &               &               &               \\
Trial start year    &       0.062***&       0.062***&       0.062***&       0.064***&       0.093***&       0.093***&       0.093***&       0.095***\\
                    &     (0.004)   &     (0.004)   &     (0.004)   &     (0.004)   &     (0.005)   &     (0.005)   &     (0.005)   &     (0.005)   \\
\shortstack[l]{Phase 2 Clinical\\(includes Phase 2/Phase 3 trials)}&       0.351***&               &       0.343***&       0.355***&       0.397***&               &       0.387***&       0.401***\\
                    &     (0.035)   &               &     (0.035)   &     (0.058)   &     (0.037)   &               &     (0.037)   &     (0.058)   \\
Phase 3 Clinical    &       0.589***&       0.586***&       0.573***&       0.595***&       0.621***&       0.617***&       0.605***&       0.626***\\
                    &     (0.050)   &     (0.050)   &     (0.050)   &     (0.110)   &     (0.054)   &     (0.054)   &     (0.054)   &     (0.114)   \\
Trial site in US=1  &       0.076*  &       0.073*  &       0.600***&       0.610***&       0.073*  &       0.070*  &       0.638***&       0.642***\\
                    &     (0.033)   &     (0.033)   &     (0.081)   &     (0.114)   &     (0.035)   &     (0.035)   &     (0.086)   &     (0.130)   \\
Drug indication for neoplasm&       3.137***&       3.129***&       3.429***&       3.453***&       3.195***&       3.185***&       3.502***&       3.521*** \\
                    &     (0.045)   &     (0.046)   &     (0.064)   &     (0.096)   &     (0.048)   &     (0.048)   &     (0.068)   &     (0.099)    \\
Received NIH funding&      -0.168** &      -0.169** &      -0.138*  &      -0.132***&      -0.181*  &      -0.182*  &      -0.145*  &      -0.141***\\
                    &     (0.065)   &     (0.065)   &     (0.065)   &     (0.018)   &     (0.071)   &     (0.071)   &     (0.071)   &     (0.017)   \\
Biomarker type: genomic&       4.716***&       4.715***&       4.725***&       4.725***&       4.750***&       4.749***&       4.762***&       4.766***\\
                    &     (0.073)   &     (0.073)   &     (0.073)   &     (0.247)   &     (0.081)   &     (0.081)   &     (0.081)   &     (0.271)   \\
Phase 2 only        &               &       0.358***&               &               &               &       0.405***&               &               \\
                    &               &     (0.035)   &               &               &               &     (0.037)   &               &               \\
Phase 2/3 Clinical  &               &       0.151   &               &               &               &       0.163   &               &               \\
                    &               &     (0.117)   &               &               &               &     (0.124)   &               &               \\
\shortstack[l]{Trial site in US=1\\$\times$Drug indication for neoplasm=1}&               &               &      -0.621***&      -0.628***&               &               &      -0.672***&      -0.673***\\
                    &               &               &     (0.088)   &     (0.111)   &               &               &     (0.093)   &     (0.130)   \\
Constant            &    -133.586***&    -133.665***&    -133.397***&    -136.362***&    -195.002***&    -195.187***&    -196.035***&    -199.952***\\
                    &     (7.274)   &     (7.275)   &     (7.268)   &     (8.352)   &    (10.493)   &    (10.495)   &    (10.491)   &    (11.274)   \\
N                   &      113410   &      113410   &      113410   &      106626   &       96254   &       96254   &       96254   &       90650   \\
* p$<$0.05, ** p$<$0.01, *** p$<$0.001 \\

\end{tabular}
\end{table}

